Medicine
Gabapentin 800 mg tablet
Gabapentin 800 mg tablet is a generic prescription medicine for oral use, made by 43 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Gabapentin Tablets, USP at 25°C (77°F), excursions permitted between…
Key facts
- Active ingredient (INN)
- Gabapentin
- Brand
- Sold under the generic name
- Strength
- 800 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 287 more
- Manufacturers
- Zydus LifesciencesIndiaLaurus LabsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaCiplaIndiaCamber PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaGranules IndiaIndiaStrides PharmaIndiaSun Pharmaceutical IndustriesIndia43 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store Gabapentin Tablets, USP at 25°C (77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02BF01 Gabapentin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2006
- Identifiers
- RxCUI 310434, 310433, 310430 +2DailyMed set ID afa28969-91ca-83fd-e053-2a95a90a656b, b1a9808d-31a5-4b63-afd0-d96d5a0ad7a1, 9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a +37NDC 80425-0035, 16571-117, 16714-332 +37Application ANDA206402, ANDA217995, ANDA200651 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 43 labelers. The register lists 290 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65841-706-01 | Zydus LifesciencesIndia | 16 October 2012 |
| 500 tablet, film coated in 1 bottle | 65841-706-05 | Zydus LifesciencesIndia | 16 October 2012 |
| 1000 tablet, film coated in 1 bottle | 65841-706-10 | Zydus LifesciencesIndia | 16 October 2012 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65841-706-77 | Zydus LifesciencesIndia | 16 October 2012 |
| 100 tablet, film coated in 1 bottle | 68382-205-01 | Zydus LifesciencesIndia | 16 October 2012 |
| 500 tablet, film coated in 1 bottle | 68382-205-05 | Zydus LifesciencesIndia | 16 October 2012 |
| 1000 tablet, film coated in 1 bottle | 68382-205-10 | Zydus LifesciencesIndia | 16 October 2012 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 68382-205-77 | Zydus LifesciencesIndia | 16 October 2012 |
| 100 tablet in 1 bottle | 67877-429-01 | Ascend LaboratoriesIndia | 1 November 2015 |
| 500 tablet in 1 bottle | 67877-429-05 | Ascend LaboratoriesIndia | 1 November 2015 |
| 1000 tablet in 1 bottle | 67877-429-10 | Ascend LaboratoriesIndia | 1 November 2015 |
| 100 blister pack in 1 carton / 10 tablet in 1 blister pack | 67877-429-38 | Ascend LaboratoriesIndia | 1 November 2015 |
| 100 tablet, film coated in 1 bottle | 65862-524-01 | Aurobindo PharmaIndia | 6 October 2011 |
| 500 tablet, film coated in 1 bottle | 65862-524-05 | Aurobindo PharmaIndia | 6 October 2011 |
| 1700 tablet, film coated in 1 bottle | 65862-524-31 | Aurobindo PharmaIndia | 6 October 2011 |
| 90 tablet, film coated in 1 bottle | 65862-524-90 | Aurobindo PharmaIndia | 6 October 2011 |
| 100 tablet in 1 bottle | 31722-167-01 | Camber PharmaceuticalsIndia | 1 October 2021 |
| 500 tablet in 1 bottle | 31722-167-05 | Camber PharmaceuticalsIndia | 1 October 2021 |
| 30 tablet in 1 bottle | 69097-811-02 | CiplaIndia | 22 July 2016 |
| 100 tablet in 1 bottle | 69097-811-07 | CiplaIndia | 22 July 2016 |
| 500 tablet in 1 bottle | 69097-811-12 | CiplaIndia | 22 July 2016 |
| 100 tablet in 1 bottle | 68462-127-01 | Glenmark PharmaceuticalsIndia | 1 April 2006 |
| 500 tablet in 1 bottle | 68462-127-05 | Glenmark PharmaceuticalsIndia | 1 April 2006 |
| 100 tablet, film coated in 1 bottle | 70010-228-01 | Granules IndiaIndia | 27 June 2023 |
| 500 tablet, film coated in 1 bottle | 70010-228-05 | Granules IndiaIndia | 27 June 2023 |
| 100 tablet, film coated in 1 bottle | 42385-980-01 | Laurus LabsIndia | 9 April 2024 |
| 500 tablet, film coated in 1 bottle | 42385-980-05 | Laurus LabsIndia | 9 April 2024 |
| 1000 tablet, film coated in 1 bottle | 42385-980-11 | Laurus LabsIndia | 9 April 2024 |
| 30 tablet, film coated in 1 bottle | 42385-980-30 | Laurus LabsIndia | 9 April 2024 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 42385-980-72 | Laurus LabsIndia | 9 April 2024 |
| 90 tablet, film coated in 1 bottle | 42385-980-90 | Laurus LabsIndia | 9 April 2024 |
| 100 tablet in 1 container | 64380-728-01 | Strides PharmaIndia | 14 June 2025 |
| 500 tablet in 1 container | 64380-728-02 | Strides PharmaIndia | 14 June 2025 |
| 100 tablet, film coated in 1 bottle | 62756-204-01 | Sun Pharmaceutical IndustriesIndia | 1 September 2022 |
| 500 tablet, film coated in 1 bottle | 62756-204-03 | Sun Pharmaceutical IndustriesIndia | 1 September 2022 |
| 100 tablet, film coated in 1 bottle | 76282-406-01 | Exelan Pharmaceuticals | 2 November 2012 |
| 500 tablet, film coated in 1 bottle | 76282-406-05 | Exelan Pharmaceuticals | 2 November 2012 |
| 30 tablet, film coated in 1 bottle | 76282-406-30 | Exelan Pharmaceuticals | 2 November 2012 |
| 90 tablet, film coated in 1 bottle | 76282-406-90 | Exelan Pharmaceuticals | 2 November 2012 |
| 500 tablet in 1 bottle | 76282-707-05 | Exelan Pharmaceuticals | 1 October 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Gabapentin 800 mg tablet.
Other strengths and forms of Gabapentin
Clinical summary
Gabapentin is an anti-epileptic agent indicated for management of postherpetic neuralgia in adults, among other approved uses. It is available as capsules, tablets and oral solution. MedsAcross supplies Gabapentin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GabapentinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neurontin prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Gabapentin 800 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.